UCSB lab discovers cross-protective vaccine

December 05, 2001

(Santa Barbara, Calif.) - New medical research at the University of California, Santa Barbara represents a significant step toward preventing infections through the development of vaccines that elicit protection against several different disease-causing strains.

The work, by UCSB biologists Douglas M. Heithoff, Steve Julio, David A. Low, Robert L. Sinsheimer, and Michael J. Mahan, is an extension of earlier breakthrough research in which a strain of Salmonella was forced, through a new DNA technology, to "show its hand," thus allowing the organism to defend against it. The technology used in this vaccine is called DNA adenine methylase, or "Dam," and was discovered by Mahan's team in 1999.

The new developments are described in articles in the November and December issues of the journal Infection and Immunity. "One of the main obstacles of vaccine development is that there are often many strains that can cause disease in individuals vaccinated against a single strain or a small set of strains," said Mahan. "This is the principle reason why different flu vaccines need to be administered every year, and why disease can occur in vaccinated individuals. This obstacle is a big problem for Salmonella, which has more than 2500 pathogenic strains. Using Dam technology, we have developed a Salmonella vaccine that is cross-protective to different salmonella strains."

He said that the development of cross-protective vaccines is paramount to the defense against biowarfare agents wherein pathogenic strains may have been "weaponized" by selecting for strains that overcome the immunity in vaccinated individuals. In effect, this renders many of our current vaccines obsolete.

In the December issue of Infection and Immunity, Mahan explains that "We have expanded the use of Dam technology to Yersinia pseudotuberculosis which is a very close cousin of the human plague-causing organism, Yersinia pestis. Dam mutants of Yersinia are completely disabled in their ability to cause disease. Immunized with these Dam mutants fully protects against Yersinia infection - in other words these immunized mice can't be killed by virulent Yersinia."

Mahan noted that his research team is now exploring whether the Salmonella Dam technology can be used to induce immunity to other bacterial and viral pathogens. This work has been recently funded by a University of California BioSTAR biotechnology grant of $1 million. (BioSTAR -- Biotechnology Strategic Targets for Alliances in Research -- is a University of California-wide biotechnology matching grants program that forges partnerships among businesses, UC scientists, engineers and students.)

The UCSB research team has formed the company Remedyne, a private biotechnology company focused on developing potent immune stimulating vaccines and antimicrobial agents to treat infectious diseases in humans, companion animals and livestock. The University of California owns the patent for the Dam technology which is licensed to Remedyne. In human health research, the company is focusing on technology to combat cancer, infections of the ear, respiratory and urinary tract.
-end-


University of California - Santa Barbara

Related Salmonella Articles from Brightsurf:

Sneaky salmonella finds a backdoor into plants
Researchers have discovered that bacteria such as salmonella, E.coli and listeria have a backdoor to take advantage of humans' reliance on leafy greens for a healthy diet.

Re-trafficking proteins to fight Salmonella infections
New study demonstrates how monitoring all cellular proteins over time and space can improve our understanding of host-pathogen interactions.

Researchers find one-two punch may help fight against Salmonella
Researchers found that dephostatin does not kill Salmonella or stop it from growing.

Food scientists slice time off salmonella identification process
Researchers from Cornell University, the Mars Global Food Safety Center in Beijing, and the University of Georgia have developed a method for completing whole-genome sequencing to determine salmonella serotypes in just two hours and the whole identification process within eight hours.

The discovery of ancient Salmonella
Oldest reconstructed bacterial genomes link agriculture and herding with emergence of new disease.

The function of new microRNAs are identified in Salmonella and Shigella infections
The research, published in Nature Microbiology, could help the search for more effective medicine and delves deeper into understanding the role of microRNAs in gene expression.

Salmonella the most common cause of foodborne outbreaks in the European Union
Nearly one in three foodborne outbreaks in the EU in 2018 were caused by Salmonella.

The nature of salmonella is changing -- and it's meaner
Salmonella is acting up in Michigan, and it could be a model for what's happening in other states, according to a new Michigan State University study.

Salmonella -- how the body fights back
New research shows how our immune system fights back against Salmonella infection.

For salmonella detection, genomic tool emerges as a key
The world's food supply will become safer as the food industry shifts to high-resolution, whole-genome sequencing -- which examines the full DNA of a given organism all at once.

Read More: Salmonella News and Salmonella Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.